Longacre TA - Search Results

1

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Ovarian Tumor Tissue Analysis (OTTA) Consortium; Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Tołoczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf A, Ryan A, Chudecka-Głaz A, Magliocco AM, Hartmann A, Jung AY, Gao B, Hernandez BY, Fridley BL, McCauley BM, Kennedy CJ, Wang C, Karpinskyj C, de Sousa CB, Tiezzi DG, Wachter DL, Herpel E, Taran FA, Modugno F, Nelson G, Lubiński J, Menkiszak J, Alsop J, Lester J, García-Donas J, Nation J, Hung J, Palacios J, Rothstein JH, Kelley JL, de Andrade JM, Robles-Díaz L, Intermaggio MP, Widschwendter M, Beckmann MW, Ruebner M, Jimenez-Linan M, Singh N, Oszurek O, Harnett PR, Rambau PF, Sinn P, Wagner P, Ghatage P, Sharma R, Edwards RP, Ness RB, Orsulic S, Brucker SY, Johnatty SE, Longacre TA, Ursula E, McGuire V, Sieh W, Natanzon Y, Li Z, Whittemore AS, Anna A, Staebler A, Karlan BY, Gilks B, Bowtell DD, Høgdall E, Candido dos Reis FJ, Steed H, Campbell IG, Gronwald J, Benítez J, Koziak JM, Chang-Claude J, Moysich KB, Kelemen LE, Cook LS, Goodman MT, García MJ, Fasching PA, Kommoss S, Deen S, Kjaer SK, Menon U, Brenton JD, Pharoah PDP, Chenevix-Trench G, Huntsman DG, Winham SJ, Köbel M, Ramus S… See abstract for full author list ➔ Ovarian Tumor Tissue Analysis (OTTA) Consortium, et al. Among authors: longacre ta. JAMA Oncol. 2017 Dec 1;3(12):e173290. doi: 10.1001/jamaoncol.2017.3290. JAMA Oncol. 2017. PMID: 29049607 Free PMC article.

2

Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.

Gilks CB, Vanderhyden BC, Zhu S, van de Rijn M, Longacre TA. Gilks CB, et al. Among authors: longacre ta. Gynecol Oncol. 2005 Mar;96(3):684-94. doi: 10.1016/j.ygyno.2004.11.039. Gynecol Oncol. 2005. PMID: 15721412

3

Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.

Brown LA, Irving J, Parker R, Kim H, Press JZ, Longacre TA, Chia S, Magliocco A, Makretsov N, Gilks B, Pollack J, Huntsman D. Brown LA, et al. Among authors: longacre ta. Gynecol Oncol. 2006 Feb;100(2):264-70. doi: 10.1016/j.ygyno.2005.08.026. Epub 2005 Oct 19. Gynecol Oncol. 2006. PMID: 16236351

4

Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.

McKenney JK, Balzer BL, Longacre TA. McKenney JK, et al. Among authors: longacre ta. Am J Surg Pathol. 2006 Oct;30(10):1209-21. doi: 10.1097/01.pas.0000213299.11649.fa. Am J Surg Pathol. 2006. PMID: 17001150 Review.

5

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays.

Bane AL, Beck JC, Bleiweiss I, Buys SS, Catalano E, Daly MB, Giles G, Godwin AK, Hibshoosh H, Hopper JL, John EM, Layfield L, Longacre T, Miron A, Senie R, Southey MC, West DW, Whittemore AS, Wu H, Andrulis IL, O'Malley FP. Bane AL, et al. Am J Surg Pathol. 2007 Jan;31(1):121-8. doi: 10.1097/01.pas.0000213351.49767.0f. Am J Surg Pathol. 2007. PMID: 17197928

6

CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.

Norton JA, Ham CM, Van Dam J, Jeffrey RB, Longacre TA, Huntsman DG, Chun N, Kurian AW, Ford JM. Norton JA, et al. Among authors: longacre ta. Ann Surg. 2007 Jun;245(6):873-9. doi: 10.1097/01.sla.0000254370.29893.e4. Ann Surg. 2007. PMID: 17522512 Free PMC article.

7

Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study.

Sangoi AR, McKenney JK, Dadras SS, Longacre TA. Sangoi AR, et al. Among authors: longacre ta. Am J Surg Pathol. 2008 Feb;32(2):261-8. doi: 10.1097/PAS.0b013e318141fc7a. Am J Surg Pathol. 2008. PMID: 18223329

8

Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.

Sangoi AR, Soslow RA, Teng NN, Longacre TA. Sangoi AR, et al. Among authors: longacre ta. Am J Surg Pathol. 2008 Feb;32(2):269-74. doi: 10.1097/PAS.0b013e31814fa9b0. Am J Surg Pathol. 2008. PMID: 18223330

9

Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.

Rogers WM, Dobo E, Norton JA, Van Dam J, Jeffrey RB, Huntsman DG, Kingham K, Chun N, Ford JM, Longacre TA. Rogers WM, et al. Among authors: longacre ta. Am J Surg Pathol. 2008 Jun;32(6):799-809. doi: 10.1097/PAS.0b013e31815e7f1a. Am J Surg Pathol. 2008. PMID: 18391748

10

Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.

Han G, Gilks CB, Leung S, Ewanowich CA, Irving JA, Longacre TA, Soslow RA. Han G, et al. Among authors: longacre ta. Am J Surg Pathol. 2008 Jul;32(7):955-64. doi: 10.1097/PAS.0b013e318164edf7. Am J Surg Pathol. 2008. PMID: 18460981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters